Results 241 to 250 of about 153,260 (300)

Antibiotic Resistance in <i>Klebsiella pneumoniae</i> and Related Enterobacterales: Molecular Mechanisms, Mobile Elements, and Therapeutic Challenges. [PDF]

Antibiotics (Basel)
Zdarska V, Arcari G, Kolar M, Mlynarcik P.   +3 more
europepmc   +1 more source

Medical dispensation in La Rioja, Spain: epidemiology and its relationship with social determinants: a descriptive study. [PDF]

Front Pharmacol
Aparicio-Rodríguez G, Juárez-Vela R, Burgos-Esteban A, Sancho-Sánchez C, Santos-Sanchez JÁ, Navas-Echazarreta N, Cobos-Rincón A, Cardoso-Muñoz A, Ruiz de Viñaspre-Hernández R, Larrayoz IM.   +9 more
europepmc   +1 more source

[Penicillins and beta-lactamase inhibitors].

Gaceta medica de Mexico, 1993
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors

Expert Opinion on Investigational Drugs, 2000
beta-Lactamase inhibitor:beta-lactam combinations remain one of the most successful strategies for the treatment of bacterial infections. Over the last 20 years the number and diversity of serine and metallo active site beta-lactamases has increased dramatically. This review highlights some of the new additions to the beta-lactamase arena and discusses
D J, Payne, W, Du, J H, Bateson
openaire   +3 more sources

A 2018–2019 patent review of metallo beta-lactamase inhibitors

Expert Opinion on Therapeutic Patents, 2020
Introduction Antibiotic resistance caused by beta-lactamase expressing bacteria poses a concern given its global dissemination and proliferation. The emergence of the metallo beta-lactamases is an indefinite health threat toward which current antibiotics
Nakita Reddy, Mbongeni Shungube, P. Arvidsson, S. Baijnath, H. G. Kruger, T. Govender, Tricia Naicker   +6 more
semanticscholar   +1 more source

Insight into the screening of potential beta-lactamase inhibitors as anti-bacterial chemical agents through pharmacoinformatics study

Journal of Biomolecular Structure and Dynamics, 2020
Drug resistance is an unsolved and major concern in the bacterial infection. Continuous development of drug-resistance to the antibiotics exponentially rises the danger of bacterial infections.
P. Parida, Shovonlal Bhowmick, A. Saha, A. Islam   +3 more
semanticscholar   +1 more source

Beta-lactamase inhibitor combinations

Medical Clinics of North America, 1995
The beta-lactamase inhibitor combinations present a novel approach to the problem of beta-lactamase-induced resistance to antibiotics. These agents are derived from the generally safe beta-lactam class of antibiotics. They are all principally excreted through the kidneys and require dosage adjustment in the face of significant renal insufficiency. They
J W, Sensakovic, L G, Smith
openaire   +2 more sources